share_log

Evelo Biosciences Q4 EPS $(0.62) Misses $(0.53) Estimate

Evelo Biosciences Q4 EPS $(0.62) Misses $(0.53) Estimate

Velo Biosciences第四季度每股收益$(0.62)$(0.53)估計
Benzinga Real-time News ·  2021/03/09 20:24

Evelo Biosciences (NASDAQ:EVLO) reported quarterly losses of $(0.62) per share which missed the analyst consensus estimate of $(0.53) by 16.98 percent. This is a 11.43 percent increase over losses of $(0.70) per share from the same period last year.

Evelo Biosciences(納斯達克：EVLO)公佈季度虧損(0.62美元/股)，低於分析師普遍預期的0.53美元(0.53美元)16.98%。這比去年同期每股虧損0.70美元增加了11.43%。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論